Company profile
Mytos - Home
The Infrastructure for Cell Manufacturing
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
13 Oct 2022 to 13 Apr 2024
In 2006, Prof. Shinya Yamanaka discovered a method by which one could turn back the developmental clock of a cell through converting a skin cell into a stem cell -- a cell that is capable of becoming any kind of cell in the body. He called this transformed cells induced pluripotent stem cells (iPSCs) -- 'pluripotent' meaning capable of becoming any cell i...
1 Mar 2020 to 31 Mar 2021
Many advanced therapies involve manual cell culture steps at manufacture. Cytera will work with Orchard Therapeutics to automate some of these manual cell culture steps which are relevant for Orchard, as well as others in the industry
